Literature DB >> 31937517

Antidepressant Use During Development May Impair Women's Sexual Desire in Adulthood.

Tierney K Lorenz1.   

Abstract

INTRODUCTION: Although antidepressants are well known to cause sexual side effects in adults, the long-term effects of antidepressant use during development on adult sexual function is unknown. AIM: To explore differences in sexual desire and sexual behavior between adults who did vs did not use antidepressants during childhood or adolescence.
METHODS: An online survey of 610 young adults (66% women) assessed childhood and current mental health and use of antidepressants and other psychiatric medications before the age of 16 years and currently, partnered and solitary sexual desire, and frequency of masturbation and partnered sexual activity. Antidepressants were coded into either selective serotonin reuptake inhibitors (SSRIs) or non-SSRI antidepressants. MAIN OUTCOME MEASURE: Scores on the Sexual Desire Inventory, and self-reported frequency of masturbation and partnered sexual activity.
RESULTS: For women, childhood SSRI use was associated with significantly lower solitary sexual desire, desire for an attractive other, and frequency of masturbation. This was true even when controlling for childhood mental health concerns, current mental health, and current antidepressant use. However, there was no effect of childhood SSRI use on women's partnered sexual desire or partnered sexual activity. There was no significant effect of childhood antidepressant use on men's sexual desire or masturbation. However, in men, childhood use of non-SSRI antidepressants was associated with significantly higher frequency of partnered sexual activity. Childhood use of non-SSRI antidepressants, or nonantidepressant psychiatric medication, was not associated with adult sexual desire or behavior in either women or men. CLINICAL IMPLICATIONS: It is possible that SSRI use during childhood interrupts the normal development of sexual reward systems, which may be a risk factor for sexual desire dysfunction in adult women. STRENGTHS & LIMITATIONS: Strengths include a large sample, use of attention checks and validated measures, and careful assessment of childhood mental health history; however, generalizability is limited by a predominantly white, young adult sample. These data are cross-sectional, and therefore, causal explanations for the association between childhood SSRI use and adult sexual well-being should be considered preliminary, warranting replication.
CONCLUSION: These findings point to a critical need for well-controlled, prospective research on possible long-term effects of antidepressant use, particularly SSRI use, on the development of adult sexual well-being. Lorenz TK. Antidepressant Use During Development May Impair Women's Sexual Desire in Adulthood. J Sex Med 2020;17:470-476.
Copyright © 2019 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antidepressants; Desire; Developmental; Sexual Function; Sexual Side Effects

Mesh:

Substances:

Year:  2020        PMID: 31937517      PMCID: PMC7197954          DOI: 10.1016/j.jsxm.2019.12.012

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  45 in total

1.  Early postnatal treatment with clomipramine induces female sexual behavior and estrous cycle impairment.

Authors:  Tania Molina-Jiménez; Ofelia Limón-Morales; Herlinda Bonilla-Jaime
Journal:  Pharmacol Biochem Behav       Date:  2018-01-31       Impact factor: 3.533

2.  Sexual Desire Inventory: Two or Three Dimensions?

Authors:  Nieves Moyano; Pablo Vallejo-Medina; Juan Carlos Sierra
Journal:  J Sex Res       Date:  2016-01-12

3.  Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005-2012.

Authors:  Christian J Bachmann; Lise Aagaard; Mehmet Burcu; Gerd Glaeske; Luuk J Kalverdijk; Irene Petersen; Catharina C M Schuiling-Veninga; Linda Wijlaars; Julie M Zito; Falk Hoffmann
Journal:  Eur Neuropsychopharmacol       Date:  2016-02-08       Impact factor: 4.600

4.  Prevalence and Predictors of Low Sexual Desire, Sexually Related Personal Distress, and Hypoactive Sexual Desire Dysfunction in a Community-Based Sample of Midlife Women.

Authors:  Roisin Worsley; Robin J Bell; Pragya Gartoulla; Susan R Davis
Journal:  J Sex Med       Date:  2017-05       Impact factor: 3.802

5.  The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management.

Authors:  Angel L Montejo; Laura Montejo; David S Baldwin
Journal:  World Psychiatry       Date:  2018-02       Impact factor: 49.548

Review 6.  Pathways of sexual desire.

Authors:  James G Pfaus
Journal:  J Sex Med       Date:  2009-04-30       Impact factor: 3.802

7.  Prenatal exposure of bupropion may enhance agitation, anxiety responses, and sensitivity to cocaine effects in adult mice.

Authors:  Shu-Wen Su; Chian-Fang G Cherng; Yin Chiu Lin; Lung Yu
Journal:  Chin J Physiol       Date:  2007-02-28       Impact factor: 1.764

8.  Involvement of ventral pallidal vasopressin in the sex-specific regulation of sociosexual motivation in rats.

Authors:  Brett T DiBenedictis; Harry K Cheung; Elizabeth R Nussbaum; Alexa H Veenema
Journal:  Psychoneuroendocrinology       Date:  2019-09-25       Impact factor: 4.905

9.  Effect of CS preexposure on the conditioned ejaculatory preference of the male rat: behavioral analyses and neural correlates.

Authors:  Gonzalo R Quintana; Misha Jackson; Mojdeh Nasr; James G Pfaus
Journal:  Learn Mem       Date:  2018-09-17       Impact factor: 2.460

10.  Plasma Oxytocin Level and Sexual Dysfunction in Depressed Women Treated by Either Fluoxetine or Citalopram: a Pilot Clinical Trial.

Authors:  Mohammad Abbasinazari; Mona Heidari-Kord; Azadeh Mazaheri-Meybodi; Azadeh Eshraghi; Nima Bayati
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

View more
  2 in total

1.  Mind-body-spirit model for the medical management of female sexual well-being.

Authors:  Tierney Lorenz; Nicola Finley
Journal:  Curr Sex Health Rep       Date:  2020-10-31

2.  Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin.

Authors:  David Healy; Audrey Bahrick; Maarten Bak; Angelo Barbato; Rocco Salvatore Calabrò; Barbara M Chubak; Fiammetta Cosci; Antonei B Csoka; Barbara D'Avanzo; Silvia Diviccaro; Silvia Giatti; Irwin Goldstein; Heiko Graf; Wayne J G Hellstrom; Michael S Irwig; Emmanuele A Jannini; Paddy K C Janssen; Mohit Khera; Manoj Therayil Kumar; Joanna Le Noury; Michał Lew-Starowicz; David E J Linden; Celine Lüning; Dee Mangin; Roberto Cosimo Melcangi; Omar Walid Muquebil Ali Al Shaban Rodríguez; Jalesh N Panicker; Arianna Patacchini; Amy M Pearlman; Caroline F Pukall; Sanjana Raj; Yacov Reisman; Rachel S Rubin; Rudy Schreiber; Stuart Shipko; Barbora Vašečková; Ahad Waraich
Journal:  Int J Risk Saf Med       Date:  2022
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.